ArticleTranslational andrology and urology2024

Effectiveness of switch therapy from tyrosine kinase inhibitors to immune checkpoint inhibitors: the need for biomarkers to establish treatment strategies in patients with metastatic renal cell carcinoma.

Yoshihiko Tasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.